Immediate Impact

85 standout
Sub-graph 1 of 23

Citing Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
2 intermediate papers

Works of Hannah Merrick being referenced

Quality of life, support and smoking in advanced lung cancer patients: a qualitative study
2014

Author Peers

Author Last Decade Papers Cites
Hannah Merrick 156 56 177 143 28 411
Jane Williams 156 47 50 162 22 427
Diana L. Velott 92 17 40 162 22 453
Kathy L. Bradley‐Klug 102 35 31 102 28 431
Anette Hauskov Graungaard 199 66 18 179 21 447
Dana Barthel 194 47 59 140 22 419
Vicki Welch 188 84 34 61 30 351
Samantha Flynn 189 26 23 51 39 391
Rita Beck Black 133 63 14 168 25 385
Jessica E. Rast 253 20 66 44 34 400
Lucy Holland 34 147 60 220 19 343

All Works

Loading papers...

Rankless by CCL
2026